Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis

MeSH terms

• Administration, Intravenous
• Bone Density Conservation Agents / adverse effects
• Bone Density Conservation Agents / therapeutic use
• Fatigue / etiology
• Humans
• Hypocalcemia / diagnosis
• Hypocalcemia / etiology*
• Hypophosphatemia / diagnosis
• Hypophosphatemia / etiology*
• Immunoglobulin Light-chain Amyloidosis / complications
• Immunoglobulin Light-chain Amyloidosis / drug therapy*
• Male
• Middle Aged
• Zoledronic Acid / adverse effects*
• Zoledronic Acid / therapeutic use